EUVIMEDEUVIMED entdecken
VergleichsstudieÄquivalenzstudieMultizentrische StudiePragmatische StudieOpen Access

Risk-Based vs Annual Breast Cancer Screening

Laura J Esserman, Allison S Fiscalini, Arash Naeim, Laura J Van't Veer, Andrea Kaster, Maren T Scheuner, Andrea Z LaCroix, Alexander D Borowsky, Hoda Anton-Culver, Olufunmilayo I Olopade, James Esserman, Rachael Lancaster und 27 weitere

JAMA · 03.03.2026 · 335 (9) · 763

DOI: 10.1001/jama.2025.24784 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 03.03.2026. Verfasst von Laura J Esserman und 38 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Early Detection of Cancer, Genetic Testing. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Individual breast cancer risk can guide screening initiation, frequency, use of supplemental imaging, and preventive measures to improve breast cancer screening by shifting resources from low-risk women to high-risk women.

Objective

To determine whether risk-based breast cancer screening is a feasible alternative to annual mammography. Design, Setting, and Participants Parallel-group, pragmatic, multicenter randomized clinical trial comparing risk-based (n = 14 212) with annual (n = 14 160) breast cancer screening. Women aged 40 to 74 years without prior diagnoses of breast cancer or ductal carcinoma in situ, or prophylactic bilateral mastectomy, were recruited from all 50 US states from September 2016 to February 2023, with follow-up through September 5, 2025 (median follow-up, 5.1 years). Statistical analysis was conducted between July and November 2025. All study procedures were conducted via an online platform. Women who declined randomization were enrolled in an observational cohort.

Interventions

Risk assessment included sequencing of 9 susceptibility genes, polygenic risk score, and the Breast Cancer Surveillance Consortium version 2 model. The risk-based group received 1 of 4 recommendations: (1) highest risk (≥6% 5-year risk, high-penetrance pathogenic variant): alternating mammography and magnetic resonance imaging (MRI) every 6 months and counseling; (2) elevated risk (top 2.5 risk percentile by age): annual mammography and risk-reduction counseling; (3) average risk: biennial mammography; and (4) low risk (aged 40-49 years and <1.3% 5-year risk): no screening until risk is 1.3% or greater or age 50 years. Main Outcomes and Measures The coprimary outcomes included noninferiority for stage ≥IIB cancers and superiority in reducing biopsy rates. Secondary outcomes included identification of stage ≥IIA cancers, mammogram rates, uptake of prevention strategies in higher risk cohorts, preference for screening group in the observational cohort, ductal carcinoma in situ, MRI, and stage-specific cancer rates.

Results

A total of 28 372 women were randomized. The mean (SD) age was 54 (9.6) years and the majority were non-Hispanic White (77%). The rate of stage ≥IIB cancers was noninferior in the risk-based compared with the annual group (risk-based: 30.0 [95% CI, 16.3-43.8] vs annual: 48.0 [95% CI, 30.1-65.5] per 100 000 person-years; rate difference, −18.0 per 100 000 person-years [95% CI, −40.2 to 4.1]). The rate of breast biopsies was not lower in the risk-based group (rate difference, 98.7 per 100 000 person-years [95% CI, −17.9 to 215.3]) despite fewer mammograms (rate difference, −3835.9 [95% CI, −4516.8 to −3154.9]). The cumulative incidence of cancer, biopsy, mammogram, and MRI increased as risk category increased. In the observational cohort, 89% of participants (15 980/18 031) chose risk based.

Conclusions

Risk-based breast cancer screening that includes population-based genetic testing safely stratified risk and screening intensity, but did not reduce biopsy rates. Trial Registration ClinicalTrials.gov Identifier: NCT02620852

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingEarly Detection of CancerGenetic TestingMammographyAdultAgedFemaleHumansMiddle AgedBiopsyBreastCounselingFeasibility StudiesFollow-Up StudiesGenetic Risk ScoreIncidenceMagnetic Resonance ImagingNeoplasm StagingRisk Assessment

Autor:innen und Institutionen

  • University of California, San Francisco.
  • University of California, Los Angeles.
  • Sanford Health, Fargo, North Dakota.
  • San Francisco VA Health Care System, San Francisco, California.
  • University of California, San Diego.
  • University of California, Irvine.

Förderung

  • NCI NIH HHS

Zitieren

APA

Esserman, L. J., Fiscalini, A. S., Naeim, A., Van't Veer, L. J., Kaster, A., Scheuner, M. T., LaCroix, A. Z., Borowsky, A. D., Anton-Culver, H., Olopade, O. I., Esserman, J., Lancaster, R., Madlensky, L., Blanco, A. M., Ross, K. S., Goodman, D. L., Tong, B. S., Hogarth, M., Heditsian, D., …, & Eklund, M. (2026). Risk-Based vs Annual Breast Cancer Screening. JAMA, 335(9), 763. https://doi.org/10.1001/jama.2025.24784

Vancouver

Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, et al. Risk-Based vs Annual Breast Cancer Screening. JAMA. 2026;335(9):763. doi:10.1001/jama.2025.24784

BibTeX
@article{Esserman2026,
  author = {Esserman, Laura J and Fiscalini, Allison S and Naeim, Arash and Van't Veer, Laura J and Kaster, Andrea and Scheuner, Maren T and LaCroix, Andrea Z and Borowsky, Alexander D and Anton-Culver, Hoda and Olopade, Olufunmilayo I and Esserman, James and Lancaster, Rachael and Madlensky, Lisa and Blanco, Amie M and Ross, Katherine S and Goodman, Deborah L and Tong, Barry S and Hogarth, Michael and Heditsian, Diane and Brain, Susie and Lee, Vivian and Blum, Kelly and Kim, Mi-Ok and Sabacan, Leah P and Fergus, Kirkpatrick B and Yau, Christina and Park, Hannah L and Parker, Barbara A and Kaplan, Celia and Rhoads, Kim F and Eder, Suzanne and Adduci, Kelly and Matthews, Jeffrey B and Wenger, Neil S and Shieh, Yiwey and Hiatt, Robert A and Ziv, Elad and Tice, Jeffrey A and Eklund, Martin},
  title = {Risk-Based vs Annual Breast Cancer Screening},
  journal = {JAMA},
  year = {2026},
  volume = {335},
  number = {9},
  pages = {763},
  doi = {10.1001/jama.2025.24784}
}
Kostenlos starten →